From: Activated phosphoinositide 3-kinase δ syndrome caused by PIK3CD mutations: expanding the phenotype
Clinical manifestation | P1 | P2 | P3 | Reference value |
---|---|---|---|---|
Age | 5Y | 7Y10M | 7Y2M | |
Gender | M | M | M | |
Main manifestations | fever, hepatosplenomegaly | abdominal pain intussusception | pneumonia, hematuria | |
Recurrent infection | yes | no | yes | |
Recurrent fever | yes | no | yes | |
Hepatosplenomegaly | yes | no | no | |
Lymphadenopathy | yes | yes | yes | |
Other exceptions | swelling of both knees | multiple polyps of intestine, thrombocytopenia | otitis media, allergic rhinitis | |
WBC(10^9/L) | 10.12 | 11.18 | 9.4 | 5.5–12 |
Hgb (g/L) | 84 | 122 | 113 | 110–149 |
PLT(10^9/L) | 146 | 20 | 131 | 100–378 |
LYM(10^9/L) | 2.05 | 1.42 | 1.27 | 1.7–4.7 |
LYM(%) | 29.0 | 16.6 | 13.5 | 22–57 |
CD16 + CD56 (n/ul) | 64 | 192 | 833 | 210–1514 |
CD19+ (n/ul) | 55 | 169 | 194 | 240–1317 |
CD3 + T (n/ul) | 1740 | 721 | 1307 | 805–4459 |
CD3 + CD8 + T (n/ul) | 1048 | 254 | 803 | 314–2080 |
CD3 + CD4 + T (n/ul) | 450 | 379 | 470 | 345–2350 |
IgG (g/L) | 0.08 | 11 | 8.21 | 3.48–7.01 |
IgM (g/L) | 1.6 | 3.57 | 1.53 | 0.42–1.73 |
IgA (g/L) | 0.26 | 2.01 | 0.45 | 0.28–1.73 |
Hematuria | (-) | (-) | (++) | (-) |
Proteinuria | (-) | (-) | (+) | (-) |
p-ANCA | / | / | (+) | (-) |
c-ANCA | / | / | (-) | (-) |
MPO (AU/ml) | / | / | (-) | < 16 |
Proteinase 3 (AU/ml) | / | / | (-) | < 16 |
EBEA-IgG | (-) | (-) | (+) | (-) |
EBV-IgG | (-) | (+) | (+) | (-) |
CMV-IgM | (-) | (+) | (-) | (-) |
CMV-IgG | (-) | (+) | (+) | (-) |